Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

Author： Hillegass W.B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.1, 2001-01, pp. : 41-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Revascularisation: A Review of Trial Reports

By Kong D.F.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 609-620

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Segment Elevation Acute Coronary Syndromes: A Review and Guide to Patient Selection

By Atwater Brett D.   Roe Matthew T.   Mahaffey Kenneth W.  

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

By  

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: Recommendations of the Rio de la Plata Expert Panel

By  

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

By Manoharan G.   Maynard S.J.   Adgey A.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 555-566

Informa Healthcare

Access to resources Recommend Favorite